Experience with citicoline in patients with post-stroke cognitive impairment
Objective: to investigate the efficacy and safety of citicoline (Ceresil® Canon) in patients with post-stroke cognitive impairment.Patients and methods. Examinations were made in 33 patients aged 45 years and older who had experienced primary ischemic hemispheric stroke with complaints of a decline...
Main Authors: | A. N. Bogolepova, S. G. Burd, A. V. Lebedeva, E. A. Kovalenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2020-08-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1410 |
Similar Items
-
CITICOLIN IN THE TREATMENT OF STROKE AND VASCULAR COGNITIVE DISORDERS
by: V. A. Parfenov
Published: (2009-12-01) -
Post-stroke cognitive impairment and treatment options
by: A. N. Bogolepova
Published: (2015-12-01) -
Citicoline for ischemic stroke: ICTUS trial
by: Vladimir Anatolyevich Parfenov
Published: (2012-12-01) -
The Effects of Citicoline on Cerebrovascular Hemodynamic Status in Ischemic Stroke Patients
by: Rostam Seifaddini, et al.
Published: (2017-11-01) -
Poststroke cognitive impairment and dementia
by: D. V. Sergeev, et al.
Published: (2016-12-01)